Form 4 for XERS Xeris Biopharma Holdings, Inc.
Accepted 2024-08-02 00:00:00 ET · period of report 2022-01-29 · accession 0001867096-24-000145 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-08-02 | 2022-01-29+ | XERS | Shannon John Patrick Jr | See Remarks, Dir | F - Tax | $2.06 | -271.6K | 2.32M | -10% | -$559.8K |
| D | 2024-08-02 | 2024-08-01 | XERS | Shannon John Patrick Jr | See Remarks, Dir | A - Grant | $0.00 | +250.0K | 2.42M | +12% | $0 |
| D | 2024-08-02 | 2024-08-01 | XERS | Shannon John Patrick Jr | See Remarks, Dir | A - Grant | $0.00 | +300.0K | 300.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-31 | F | D | 7,497 | $2.11 | 2,396,423 | D | — | — | (F3) This transaction is being reported late due to administrative oversight. (F5) Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 31, 2022. |
| 2 | Common | Common Stock | 2023-01-03 | F | D | 41,334 | $1.12 | 2,355,089 | D | — | — | (F3) This transaction is being reported late due to administrative oversight. (F6) Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 3, 2023. |
| 3 | Common | Common Stock | 2023-01-29 | F | D | 23,414 | $1.26 | 2,331,675 | D | — | — | (F3) This transaction is being reported late due to administrative oversight. (F7) Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 29, 2023. |
| 4 | Common | Common Stock | 2024-01-03 | F | D | 40,834 | $2.24 | 2,280,961 | D | — | — | (F3) This transaction is being reported late due to administrative oversight. (F9) Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 3, 2024. |
| 5 | Common | Common Stock | 2024-01-29 | F | D | 22,150 | $2.66 | 2,258,811 | D | — | — | (F3) This transaction is being reported late due to administrative oversight. (F10) Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 29, 2024. |
| 6 | Common | Common Stock | 2024-01-31 | F | D | 110,750 | $2.46 | 2,148,061 | D | — | — | (F3) This transaction is being reported late due to administrative oversight. (F11) Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 31, 2024. |
| 7 | Common | Common Stock | 2024-08-01 | A | A | 250,000 | $0.00 | 2,419,612 | D | — | — | (F1) These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years. (F2) These shares include 11,037 shares that were purchased on June 30, 2024, due to participation by the reporting individual in the issuer's 2018 Employee Stock Purchase Plan. |
| 8 | Common | Common Stock | 2022-01-29 | F | D | 15,692 | $2.11 | 2,403,920 | D | — | — | (F3) This transaction is being reported late due to administrative oversight. (F4) Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 29, 2022. |
| 9 | Common | Common Stock | 2023-01-31 | F | D | 9,880 | $1.24 | 2,321,795 | D | — | — | (F3) This transaction is being reported late due to administrative oversight. (F8) Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 31, 2023. |
| 10 | Derivative | Stock Appreciation Right | 2024-08-01 | A | A | 300,000 | $0.00 | 300,000 | D | $2.43 · — to 2026-09-01 | 300,000 Common Stock | (F12) The award will vest in full on the two-year anniversary of the grant date. |